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Abstract: The importance of ensuring adequate choline intakes during pregnancy is increasingly
recognized. Choline is critical for a number of physiological processes during the prenatal period with
roles in membrane biosynthesis and tissue expansion, neurotransmission and brain development,
and methyl group donation and gene expression. Studies in animals and humans have shown that
supplementing the maternal diet with additional choline improves several pregnancy outcomes
and protects against certain neural and metabolic insults. Most pregnant women in the U.S. are not
achieving choline intake recommendations of 450 mg/day and would likely benefit from boosting
their choline intakes through dietary and/or supplemental approaches.
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1. Introduction
The importance of ensuring adequate choline intakes during pregnancy is increasingly recognized.
The American Medical Association (AMA) in 2017 published new advice stating that prenatal vitamin
supplements should contain ‘evidence-based’ amounts of choline [1]. Similarly, in 2018, the American
Academy of Pediatrics recognized choline as a ‘brain-building’ nutrient and called upon pediatricians
to ensure pregnant women and young children have adequate intakes of choline [2].
Choline, like vitamin D and docosahexaenoic acid (DHA), can be synthesized in the body but
not in amounts sufficient to meet metabolic demands. In 1998, choline was recognized as an essential
nutrient by the Institute of Medicine (now National Academy of Medicine) when it established dietary
recommendations in the form of adequate intakes [3]. The choline adequate intake (AI) level is 425 mg
choline/day for women of reproductive age with upward adjustments to 450 mg choline/day during
pregnancy and 550 mg choline/day during lactation [3]. Although widely distributed in the diet,
choline is absent from most prenatal vitamins currently on the market, and less than ten percent of
pregnant women achieve target intake levels [4].
2. Food Sources of Choline
Choline is found in both animal and plant source foods; however, animal source foods typically
contain more choline per gram of food product. Beef, eggs, chicken, fish, and pork are concentrated
sources of choline providing more than 60 mg per 100 g [5]. Among plant source foods, nuts, legumes,
and cruciferous vegetables (e.g., broccoli) are relatively good sources providing at least 25 mg per
100 g [5]. Although not a concentrated source, cow’s milk is a main contributor to dietary choline
intake in the U.S. [6].
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Various forms of choline are found in food. The most prominent dietary form of choline is usually
phosphatidylcholine (PC) with smaller amounts of free choline, phosphocholine, sphingomyelin,
glycerophosphocholine, and lysophosphatidylcholine (LPC) [5]. All of these choline forms are
interchangeable within the body and contribute to an individual’s “total” choline intake. Although
betaine is a choline derivative, it is not considered a dietary source of choline because there is no direct
route for converting betaine to choline. However, dietary betaine may have a choline-sparing effect
since it participates in the remethylation of homocysteine, thus reducing the need for endogenous
choline oxidation to betaine [7] and lowering the dietary requirement for choline. Upon absorption
of choline, water-soluble biomolecules (free choline, phosphocholine and glycerophosphocholine)
enter portal blood, while lipid-soluble forms (PC, LPC and sphingomyelin) are incorporated into
chylomicrons [8].
3. Choline Function
Within the body, choline is critical for a number of functions with wide-ranging roles in metabolic
and physiologic processes. The choline derivative, PC, is a major constituent of all cell membranes
and is required for the biosynthesis of lipoproteins, including very low-density lipoproteins (VLDLs),
which facilitate the hepatic export of lipid (Figure 1). Inadequate choline intake disturbs the integrity
of cellular membranes resulting in ‘leaky membranes’ [9] and impairs the mobilization of fat from liver
resulting in fatty liver [10]. Acetylcholine functions as a neurotransmitter in both the central nervous
system (CNS) and the peripheral nervous system (PNS). In the CNS, cholinergic projections from the
basal forebrain to the cerebral cortex and hippocampus support the cognitive functions of those target
areas [11]. In the PNS, acetylcholine activates skeletal muscle and is a major neurotransmitter in the
autonomic nervous system [12]. Sphingomyelin is a constituent of the myelin sheath [13], which covers
the axons of nerve cells and facilitates efficient transmission of nerve signals. Finally, betaine is a
source of methyl groups for S-adenosylmethionine (SAM)-dependent methyltransferases and for folate
mediated one-carbon metabolism following the demethylation of dimethylglycine (produced when
betaine is used as a methyl donor) within the mitochondria of hepatocytes [8].
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the developing fetus. In the liver, choline can be used to make phosphatidylcholine (PC) through
the cytidine diphosphate (CDP)-choline pathway (CDP-PC), or it can be oxidized to betaine and
serve as a source of methyl groups for PC synthesis via the de novo phosphatidylethanolamine
N-methyltransferase (PEMT) pathway (PEMT-PC). Both pathways are upregulated during the third
trimester of pregnancy, but PEMT-derived PC is preferentially partitioned to the developing fetus. CM,
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4. Choline Metabolism
Choline metabolism to its various biomolecules occurs mostly in the liver (Figure 1), with the
exception of acetylcholine generation, which occurs in both cholinergic neurons and the placenta [14].
In liver (and other nucleated cells), free choline is initially partitioned to the cytidine diphosphate
(CDP)-choline pathway (also known as the Kennedy pathway) for the generation of PC, a phospholipid
that can further contribute its phosphocholine headgroup to ceramide for the synthesis of sphingomyelin.
Alternatively, free choline can be oxidized to betaine in a two-step irreversible reaction catalyzed
by choline dehydrogenase (CHDH) and betaine aldehyde dehydrogenase. The oxidation of choline
to betaine has been referred to as a ‘spillover’ pathway [15] that is most active under conditions
of surplus choline. Betaine participates in the remethylation of homocysteine to methionine by
betaine-homocysteine S-methyltransferase (BHMT). Methionine can subsequently be converted
to SAM, the universal methyl donor for over 100 cellular methylation reactions including the
phosphatidylethanolamine N-methyltransferase (PEMT) pathway.
The PEMT pathway facilitates de novo choline biosynthesis whereby phosphatidylethanolamine
(PE), a non-choline containing phospholipid, undergoes sequential methylation to PC using SAM as the
methyl donor (Figure 1). Primary sources of the methyl groups used for SAM-dependent methylation
of PE include methionine, methyl-folate, and choline itself following its oxidation to betaine. Indeed,
tracer studies in pregnant women have demonstrated substantial use of choline-derived methyl groups
for the synthesis of PC via the PEMT pathway [16]. An explanation for this apparent inefficiency
may stem from differences in the fatty acid composition of the PC molecules derived from the PEMT
pathway as opposed to the CDP-choline pathway. PEMT derived PC molecules are enriched in
long-chain polyunsaturated fatty acids (PUFAs) (C18–C22), whereas CDP-PC molecules are enriched
in saturated fatty acids (C16, C18) [17]. Both PEMT and CDP-choline derived PC molecules can be
incorporated into VLDL and exported from liver to circulation for uptake by other tissues including
the placenta (Figure 1).
During the third trimester of pregnancy, the activities of the CDP-choline and PEMT pathways
are upregulated; however, only the PC products derived from the PEMT pathway are enriched in
cord plasma [16], demonstrating preferential transport of PEMT derived PC to the developing fetus.
This preferential shuttling of PEMT-derived PCs during the third trimester may be due to its enrichment
in DHA (22:6n3), a polyunsaturated omega 3 fatty acid that accumulates in the neonatal brain during
the third trimester of pregnancy [18]. Notably, studies in women of reproductive age have shown that
choline supplementation upregulates the PEMT pathway [16] and results in greater enrichment of
PC-DHA in circulating red blood cells [19], suggesting that choline supplementation may be a strategy
for improving the bioavailability of DHA.
In addition to PC-DHA, LPC-DHA, a hydrolytic product of PEMT-PC, may represent another
source of DHA for the developing fetus [20]. LPC-DHA circulates bound to albumin and can be
taken up by the placenta via the major facilitator superfamily domain 2 protein (MFSD2A), an LPC
symporter with high affinity for LPC-DHA [21,22]. Genetic loss of MFSD2A expression in mice results
in impaired accretion of DHA in the fetal brain and eye, suggesting that LPC-DHA is a critical form of
DHA for transport across the placenta, the fetal blood-brain barrier and/or the retinal epithelium [23].
The metabolism of choline is influenced by single nucleotide polymorphisms (SNPs) found in genes
that encode enzymes in folate and choline dependent pathways [24]. For example, loss-of-function
variants in folate metabolizing enzymes (e.g., methylenetetrahydrofolate reductase [MTHFR],
5-methyltetrahydrofolate-homocysteine methyltransferase [MTR], and methylenetetrahydrofolate
dehydrogenase 1 [MTHFD1]) strain cellular PC production, possibly via impaired folate-dependent
PEMT-PC biosynthesis, even when the choline AI is consumed [25]. Similarly, disturbances in the
metabolic partitioning of choline have been observed at levels of choline intake approximating the
choline AI among women harboring SNPs within choline metabolizing enzymes (PEMT, CHDH,
BHMT, and choline kinase alpha [CHKA]) [26]. Some of these SNPs have also been shown to influence
the risk of developing organ dysfunction, a manifestation of choline deficiency, when dietary choline
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intake is restricted [27]. Overall these “risk” genotypes would be expected to increase the dietary
requirement for choline.
5. Choline and Fetal Development
During fetal development, large amounts of choline-derived phospholipids, such as
phosphatidylcholine and sphingomyelin, are needed to support rapid cell division, growth,
and myelination. The choline derived neurotransmitter acetylcholine influences many processes
in the developing brain (e.g., progenitor cell proliferation and differentiation, neurogenesis, gliogenesis,
cell survival, morphology and migration, and synaptic plasticity) [28,29], and supports normal
development of the hippocampus [30], a region of the brain with roles in learning, memory, and attention.
As a major source of methyl groups, choline also facilitates methylation of cytosine residues within
promoter regions of the placental and fetal genome, an epigenetic modification that influences gene
expression and can have lasting effects on metabolic and physiologic processes [31].
6. Choline and Pregnancy Outcomes
Choline intake during pregnancy has been shown to influence numerous metabolic and physiologic
processes as outlined below and highlighted in Figure 2.
Figure 2. An overview of the effects of maternal choline intake during pregnancy on physiological
processes and health outcomes.
6.1. Epigenetic Programming of Postnatal Health
As a methyl donor, choline influences DNA and histone methylation – two central epigenomic
processes that regulate gene expression [31]. During murine pregnancy, maternal choline deficiency
has been shown to modulate the epigenome of the offspring, with lasting adverse effects on functions
related to fetal growth [32] as well as brain development and angiogenesis [33,34]. Rodent studies have
also demonstrated modulatory effects of maternal choline supplementation during pregnancy on the
placental and fetal epigenome [35–37], with some reports of reduced disease risk [36,37]. In humans,
gestational choline may influence offspring stress reactivity. Consumption of a higher maternal choline
intake (930 vs. 480 mg choline/day) throughout the third trimester of pregnancy increased promoter
region methylation of the placental corticotropin-releasing hormone (CRH) gene and decreased its
expression (Table 1) [38]. CRH is a regulatory protein in the hypothalamus-pituitary-adrenal (HPA)
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axis that mediates stress reactivity by stimulating cortisol production by the adrenal gland. Like the
brain, the placenta makes CRH, which can subsequently enter fetal circulation and activate the HPA
axis [39]. As expected, this same study found lower cord blood cortisol concentrations in the newborns
of mothers consuming 930 vs. 480 mg choline/day. Because a heightened response to stress increases
the risk of depression, hypertension, type 2 diabetes mellitus, and immunological disorders later in
life [40,41], the children with decreased stress-reactivity at birth may be less likely to develop mental
and cardio-metabolic diseases [42].
Table 1. Human studies with a focus on maternal choline intake (or status) and pregnancy and child
health outcomes (in chronological order).
Study Design Intervention/CholineMarker Measurement





intake during the 3 months
before conception
Reduced neural tube defect (NTD)
risk with higher maternal choline







Maternal serum total and
free choline throughout
gestation and cord blood
choline concentrations
No association between child
intelligence quotient (IQ) scores at
5 years of age and maternal or










Reduced NTD risk with higher
serum choline concentrations
(n = 80 NTD and 409 control)
[45]




Better cognitive scores in
18-month-old infants with higher
maternal plasma free choline








intake in the 1st and 2nd
trimester of pregnancy
No association between cognitive
performance in 3-year-old
children and maternal choline







Controlled feeding of 930
versus 480 mg choline/day
for 12 weeks during 3rd
trimester of pregnancy
Higher placental CRH promoter
methylation and lower cord blood
cortisol concentrations in the 930
mg/d (n = 13) versus 480 mg/day
(n = 13) choline intake group.
[38]
Cheatham




trimester of pregnancy to
90 days postpartum
No effect on development or
memory in 10 or 12-month-old
infants (intervention group n = 49,







intake in the 2nd trimester
of pregnancy
Better visual memory in
7-year-old children with top
interquartile dietary choline




Controlled feeding of 930
versus 480 mg choline/day
for 12 weeks during 3rd
trimester of pregnancy
Lower placental sFlt1 mRNA
expression and maternal serum
sFLT1 levels in the 930 mg/day









of PC to infants until 3
months of age
Greater attention development in
5-week-old infants in the
intervention group (n = 36) versus
control (n = 40)
[51]
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Table 1. Cont.
Study Design Intervention/CholineMarker Measurement








of PC to infants until 3
months of age
Reduced attentional problems and
social withdrawal in children at 40
months of age in the intervention





Controlled feeding of 930
versus 480 mg choline/day
for 12 weeks during 3rd
trimester of pregnancy
Faster information processing
speed in infants during 4–13
months in the 930 (n = 12) versus








Better eyeblink conditioning in
infants at 6.5 months, higher
novelty preference scores at 12
months, and more catch-up
growth at both time points in the
choline treated group (n = 32)








week 16 of gestation
Improved development of
cerebral inhibition in newborns
and behavioral regulation in
1-year-old infants born to infected





et al. 2019 a RCT
Controlled feeding of 930
versus 480 mg choline/day
for 12 weeks during 3rd
trimester of pregnancy
Better performance on a task of
color-location memory at age 7
years in the 930 mg choline/day (n
= 11) versus 480 choline mg/day
(n = 9) choline intake group.
[56]
a These articles are based on the same controlled feeding study; b These articles are based on the same RCT.
6.2. Placental Function
The placenta is a critical organ of pregnancy that mediates nutrient and oxygen supply to the
developing fetus. Proper functioning of the placenta depends on development of a vasculature that
enables sufficient blood flow to the developing fetus. Inadequate vascularization of the placenta can lead
to pregnancy disorders characterized by impaired fetal growth such as intrauterine growth restriction
(IUGR) and preeclampsia [57]. Emerging data from a growing number of studies suggest that choline
supply can beneficially influence functional processes of the placenta, including angiogenesis [50,58,59],
inflammation [58–60], and macronutrient transport [61]. Based on rodent data, prenatal choline may
also be a nutritional approach to mitigate placental insufficiency [60,62]. In the Dlx3 ±mouse model of
placental insufficiency, gestational choline improved early fetal growth [62], possibly by increasing the
size of the placental labyrinth [60], a region of the placenta that contains the villi where nutrients pass
from the maternal blood into the fetal blood.
In humans, consumption of additional choline (930 vs. 480 mg choline/day) during the third
trimester of pregnancy reduced the production of placental soluble fms-like tyrosine kinase 1 (sFlt1) [50]
(Table 1), an anti-angiogenic protein that sequesters vascular endothelial growth factor (VEGF) in
maternal circulation and contributes to endothelial dysfunction, hypertension, and proteinuria in
preeclampsia. Downregulation of placental sFLT1 production by high choline was also demonstrated in
an in-vitro follow-up study using human trophoblast cells [58], an effect that appeared to be mediated
through attenuation of the protein kinase C (PKC) signaling pathway.
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6.3. Macronutrient Metabolism and Energy Homeostasis
Several studies have demonstrated an interaction between choline and macronutrient metabolism
during pregnancy [63–65]. In a mouse model of high-fat feeding-induced gestational diabetes mellitus
(GDM), Nam et al. [63] found that maternal choline supplementation prevented fetal overgrowth during
mid-gestation, the most common complication of GDM. This effect was associated with a dampening
of the mechanistic target of rapamycin (mTOR) signaling pathway in the placenta, which promotes
placental transport of glucose and fat [63,66,67]. A follow-up study at a later gestational time point
reported that maternal choline supplementation normalized whole-body adiposity and reduced
hepatic triglyceride accumulation possibly by downregulating lipogenic gene expression in the GDM
mouse embryos [64]. In addition, an examination of the placental structure suggested that choline
supplementation mitigated the increase in both placental junctional zone thickness and number of
glycogen cells in GDM rodent placentas [65]. Betaine supplementation of GDM mice showed similar,
but not identical, phenotypic outcomes suggesting that the beneficial effects of choline supplementation
on GDM fetal metabolism may be partially mediated via its oxidation to betaine [68]. While the
long-term outcome of maternal choline supplementation on GDM offspring metabolism remains to
be determined, methyl donor supplementation during murine pregnancy has been shown to block
some of the adverse effects of maternal high fat feeding on offspring physiology possibly by reversing
diet-induced global hypomethylation within the offspring CNS [69].
6.4. Neurodevelopment and Cognitive Function
Studies in rodents have consistently shown that high choline intake during gestation improves
cognitive function in adulthood and prevents the memory decline associated with old age [70–72].
Likewise, many studies have shown that choline inadequacy during gestation adversely influences
offspring brain development and function [33,34,73–76]. For example, piglets born to choline-deficient
mothers had lower brain weight, volume, and less white and grey matter at 30 days of age as compared
to control piglets [73–75]. A recent study reported that low choline during gestation also disrupted
retinal development and visual function in mice [77]. Possible mechanisms by which maternal choline
influences offspring neurodevelopment and cognitive function are related to (i) the use of choline for
phospholipid membrane synthesis; (ii) facilitation of DHA uptake [21]; (iii) myelination of neurons
during early development [13,78]; (iv) alterations in hippocampal acetylcholine metabolism [28,79];
(v) modulation of neurogenesis and neuronal differentiation [76,77]; and (vi) modifications on
epigenetic marks that govern hippocampal angiogenesis and cellular proliferation [33,34]. All of
these choline-induced outcomes ultimately influence cellular proliferation, differentiation, morphology,
dendritic branching, neurogenesis, and potentiation of the offspring hippocampus [76,80–82].
A few prospective observational studies have explored the relationship between maternal choline
status (intake or blood levels) during human pregnancy and cognitive development in children
(Table 1). Wu et al. found that concentrations of maternal plasma choline and betaine at 16 weeks of
gestation were positively associated with infant cognitive test scores at 18 months [46]. The Project
Viva study observed an association of better visual memory among 7-year-old children of mothers with
choline intakes in the top versus the bottom quartile during the second trimester of pregnancy [49].
Most recently, higher serum choline concentrations in mothers with infections at gestational week
16 were associated with better inhibition of auditory cerebral response in newborns and improved
development of self-regulation in 1-year old infants [55].
Findings from randomized clinical trials (RCTs) in support of a beneficial effect of prenatal choline
on cognitive outcomes are also beginning to emerge (Table 1). In a randomized controlled feeding
study, faster processing speed was observed among infants born to mothers consuming 930 versus
480 mg choline/day during their third trimester of pregnancy [53]. Moreover, children whose mothers
consumed 930 (versus 480) mg choline/day performed significantly better on a task of color-location
memory at age 7 years, suggesting a long-term beneficial effect of prenatal choline supplementation on
offspring cognition [56]. Another RCT reported improved cerebral inhibition, an indicator of attention,
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among offspring at 5 weeks of age [51], and reduced attentional problems and social withdrawal at
40 months of age [52] with choline supplementation given from the second trimester of pregnancy,
and then postnatally to the infant.
However, not all studies have found a relationship between maternal choline status/intake and
indicators of offspring cognition, which may indicate (among other things) that not all aspects of
cognition are choline-responsive. Signore et al. [44] found no associations between cord blood choline
concentrations and intellectual quotient (IQ) scores in children at 5 years of age, while Villamor et al. [47]
reported no associations between maternal choline intake and vocabulary or visual-motor scores in
children at 3 years of age. In addition, an RCT [48] that randomized women to supplemental choline
(750 mg/day) or placebo from 18 weeks gestation through 90 days postpartum reported no benefit of
maternal choline supplementation on infant cognition as assessed using a variety of cognitive domains
including general cognitive function, language development, and episodic and visuospatial memory.
6.5. Protection from Neural Insults
In addition to improving some aspects of offspring cognition, findings from animal studies show
that perinatal choline protects the brain from the neuropathological changes associated with Alzheimer’s
disease (AD) [83,84], fetal alcohol syndrome [85–87], autism [88,89], Down syndrome [90–93],
and early-life iron deficiency [94,95]. In the Ts65DN mouse model of Down syndrome, maternal
choline supplementation improved spatial memory and hippocampal neurogenesis in the brains of
the Ts65Dn offspring [90]. Notably, mechanistic studies in which a choline tracer was administered to
the adult Ts65DN offspring indicated that prenatal choline permanently upregulated PEMT activity
and the delivery of PEMT derived PC (enriched in DHA) to the brains of these mice [93]. Maternal
choline supplementation also normalized the number and density of cholinergic neurons in the medial
septum [92]. Since the loss of cholinergic neurons is often seen in AD, studies on the trisomy mice
highlight the potential of maternal choline supplementation as a preventative measure for early-onset
AD [96]. Indeed, in the APP/PS1 mouse model of AD, perinatal choline supplementation reduced the
number and total area of amyloid plaque [83]. Interestingly, cross-generational effects of perinatal
choline have been observed with fewer cognitive deficits in the F2 generation of APP/PS1 mice born to F1
mice that were not supplemented with additional choline during pregnancy themselves [84]. Prenatal
choline supplementation also mitigated long-term neurobehavioral abnormalities and transcriptomic
alterations in gene networks associated with autism and schizophrenia in rat offspring exposed to
fetal-neonatal iron deficiency [94,95].
Although few human studies have explored the effects of maternal choline supplementation on
cognitive deficits arising from neural insults, preliminary data from a recent study found that this
intervention mitigated some of the adverse effects of prenatal alcohol exposure on infant growth and
cognitive function (Table 1) [54]. These beneficial effects of prenatal choline in fetal alcohol exposure
echoed the data from alcohol-exposed animals and could be related to choline’s role as a methyl donor
and its ability to counter epigenetic changes that occur in various brain regions as a consequence
of prenatal alcohol exposure [97,98]. Prenatal choline may also protect against the development of
congenital malformations of the central nervous system, commonly referred to as neural tube defects
(NTDs). For example, both maternal choline intake and biomarkers of choline status during pregnancy
have been inversely associated with offspring NTD risk [43,45].
7. Choline Requirements during Pregnancy
The endogenous synthesis of choline via the PEMT pathway is elevated during the second half of
pregnancy due to increases in estrogen and upregulation of the PEMT gene, which contains estrogen
response elements within its promoter region [99]. However, as previously mentioned, the upregulation
of the PEMT pathway increases the demand for methyl groups from various sources including choline
itself [16]. Indeed, data from human feeding studies suggest that the choline adequate intake (AI) of
450 mg/day may not be sufficient in meeting the demands of pregnancy. For example, pregnant women
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consuming 480 mg choline/day exhibit 40–60% lower circulating concentrations of the choline-derived
methyl metabolites, betaine, dimethylglycine, and sarcosine as compared to nonpregnant women
consuming this same level of choline intake [100]. The partitioning of choline towards betaine (versus
the CDP-choline pathway) is also diminished among pregnant (versus nonpregnant) women with
choline intakes of 480 mg/day, despite greater use of betaine as a methyl donor in the pregnant state [16].
Notably, a doubling of choline intake during pregnancy (i.e., 930 versus 480 mg choline/day) restores
the partitioning of choline between the oxidative and CDP-choline pathways to that of a nonpregnant
state [16]; it also increases circulating concentrations of choline-derived methyl metabolites [100],
increases placental DNA methylation [38], and overcomes some of the metabolic inefficiencies caused
by common polymorphisms in folate and choline metabolizing genes [25,26]. Moreover, this higher
level of choline intake beneficially influenced several pregnancy outcomes including improvements
in indicators of neonatal stress reactivity [38], reductions in placental sFLT1 production [50], faster
information processing speed among infants [53], and better memory in children at age 7 years [56].
8. Safety
The tolerable upper intake level (UL) of choline is 3.5 g/day for adults and was established
to prevent hypotension and fishy body odor [3]. To date, none of the RCTs conducted in healthy
pregnant women have reported any adverse effects of choline supplementation at levels ranging
from 550–900 mg/day [48,51,100]. However, a few animal studies have reported that supplementing
the maternal diet with very high levels of methyl nutrients (with choline as one of the components)
increased susceptibility to colitis [101] and asthma-like allergic airway disease [102], as well as impaired
energy homeostasis when combined with prenatal protein restriction [103]. In addition, choline can be
converted to trimethylamine N-oxide (TMAO), a risk indicator of cardio-metabolic diseases, via the
action of gut microbes. However, whether TMAO has a causative role in human chronic disease
development is unknown [104,105], and the long-term influence of choline intake on maternal and
offspring TMAO status and health requires further investigation. In summary, certain aspects of fetal
development may follow a U-shaped response pattern to choline supply (and other methyl donors),
whereby both low and excessively high exposures could adversely influence offspring health.
9. Conclusions and Future Directions
Data from both animal and human studies highlight the importance of ensuring an adequate
choline intake during pregnancy. Supplementing the maternal diet with additional choline has been
shown to improve offspring cognition, neurodevelopment, and placental functioning, and to protect
against neural and metabolic insults. However, RCTs on prenatal choline and pregnancy outcomes
are limited and the dose–response relationship between maternal choline intake and offspring health
remains to be fully discerned. Future clinical interventions with larger sample sizes, multiple dosages,
specific endpoints with clinical utility, mechanistic measurements, and long-term follow-up are needed
to establish maternal choline intake recommendations that optimize fetal development and reduce the
risk of pregnancy complications. In the interim, consumption of 450–1000 mg choline/day appears to
be an intake level that would support fetal development and improve pregnancy outcomes based on
the available and emerging science.
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